We invest across the global healthcare industry and investments are made across the capital structure in one of two complementary strategies: private equity and public equity.
The art of investing in the science of life.
Ally Bridge Group is a global healthcare investment management firm focused on high-impact life science innovation. The firm was founded in 2013 by Frank Yu, Chief Executive Officer and Chief Investment Officer, and manages assets from offices in New York and Hong Kong.
Since our establishment, we have been the lead or co-lead on over $6 billion of transactions across healthcare subsectors. Our mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. We aim to achieve this by blending deep scientific and clinical research with proven M&A and capital markets expertise.
Bridging the Gap Between Private and Public Markets.
Private Equity
Our initial platform established in 2013.
Public Equity
A long-biased strategy launched in 2018.
We seek to deliver superior returns through our understanding of value across private and public markets.
Global Knowledge. Local Talent. Cross Market Expertise.
We aim to reap synergies across our private equity and public equity platforms, by attempting to leverage the strength of our global franchise to source and secure opportunities for our investors in high-impact life science innovation.
Leadership
Frank Yu
Founder, Chief Executive Officer, Chief Investment Officer
Frank Yu founded Ally Bridge Group in 2013 and is Chief Executive Officer and Chief Investment Officer. In this capacity, Frank is responsible for setting firmwide strategic initiatives and leading investment objectives across high-impact life science transactions in private and public markets globally. Before founding Ally Bridge Group’s predecessor company in 2009, Themes Investment Partners, Frank was a Managing Director and Head of China Investments at Sculptor Capital Management (formerly Och-Ziff Capital Management). Before that, Frank spent nearly a decade at Goldman Sachs in Hong Kong, initially in Credit Risk Management and then Investment Banking Division as a Managing Director where he was Head of Financial Institutions, Greater China, and then Head of Principal Investment Origination. Frank began his career as a Research Associate at Moody’s in New York before joining Credit Suisse as a Risk Officer in London and then Hong Kong. Frank holds a BA in Economics and Applied Mathematics from Queens College of the City University of New York.
Frank currently serves on the Board of Trustees to the Solomon R. Guggenheim Foundation and on the Advisory Board to the Hong Kong Life Sciences Society.
Investment Team
Kevin Reilly
Managing Director, Head of Medtech
Private Equity
Kevin Reilly joined Ally Bridge Group in 2021 and is a Managing Director, Head of Medtech, for the private equity strategy focused on transactions across healthcare subsectors. Before joining Ally Bridge Group, Kevin was a Principal at CRG, a healthcare investment management firm providing growth capital to companies through the form of long-term debt and equity. Kevin began his career in the Healthcare Investment Banking Group at Stifel Nicolaus. Kevin holds a BS in Finance and Information Systems from the University of Maryland.
Andrew Lam, PharmD
Managing Director, Head of Biotech
Private Equity
Andrew Lam joined Ally Bridge Group in 2021 and is a Managing Director, Head of Biotech, for the private equity strategy focused on investments in biotech. Before joining Ally Bridge Group, Andrew was Senior Director of Business Development at Intercept Pharmaceuticals. Before that, Andrew was a Vice President, Healthcare Investment Banking at Jefferies and an Equity Research Associate at BMO Capital and Canaccord Genuity. Andrew began his career at several biotechnology companies, including Celgene and Shire. Andrew holds a PharmD from Long Island University and received an MBA from Drexel University.
Reese Yeh
Managing Director
Private Equity
Reese Yeh is a Managing Director for Ally Bridge Group’s private equity strategy focusing on deal execution of transactions and investments in biopharmaceuticals. Before joining Ally Bridge Group’s predecessor company in 2012, Themes Investment Partners, Reese worked at Morgan Stanley where she focused on private equity transactions across Greater China and the Southeast Asia region. Reese holds a BBA in Finance from National Taiwan University.
Sebastian Paquette, CFA
Principal
Private Equity
Sebastian Paquette joined Ally Bridge Group in 2021 and is a Principal for the private equity strategy focused on investments in digital health and medical devices. Before joining Ally Bridge Group, Sebastian was the Director of Healthcare at Solid Rock Group. Prior to that, Sebastian founded two healthcare companies focused on surgeon practice restructuring and medical device supply chain efficiency. Sebastian began his career at Goldman Sachs as a Research Analyst. Sebastian holds a BA in Psychology from Boston College. He is a CFA charterholder.
Tinnie Chau, CFA
Principal
Private Equity
Tinnie Chau joined Ally Bridge Group in 2015 and is a Principal for the private equity strategy focused on investments in therapeutics. Before joining Ally Bridge Group, Tinnie was a Manager in the Corporate Finance department of PricewaterhouseCoopers, providing advisory services on M&A transactions across industries with a focus in the healthcare sector. Tinnie holds a BA and MA in Biological Natural Sciences from the University of Cambridge. She is a CFA charterholder.
Steven Plachtyna
Vice President
Private Equity
Steven Plachtyna joined Ally Bridge Group in 2020 and is a Vice President for the private equity strategy focused on investments in medical technology, tools and diagnostics. Before joining Ally Bridge Group, Steven was a Senior Research Associate at Citi Group and Bank of Montreal Capital Markets. Steven began his career at Medtronic in Research and Development. Steven holds a BS in Biomedical Engineering from the University of Connecticut, where he graduated cum laude, and he received a MEng in Biomedical Engineering and an MBA from Cornell University.
Paresh Kumar, PharmD, JD
Vice President
Private Equity
Paresh Kumar joined Ally Bridge Group in 2024 and is a Vice President for the private equity strategy focused on investments in biotech. Before joining Ally Bridge Group, Paresh was a senior associate at Goodwin Procter in its Life Sciences practice where he executed complex corporate financing and strategic transactions representing biotech and medtech companies. Previously, Paresh was an associate at Morrison & Foerster and McDermott Will & Emery. He also worked in Boston University’s technology transfer office and interned at MPM Capital. Paresh started his career as a financial analyst at Takeda. Paresh holds a B.S. and a Pharm.D. from Northeastern University, and a J.D. from Boston University.
Keith Lee
Senior Associate
Private Equity
Keith Lee joined Ally Bridge Group in 2022 and is a Senior Associate for the private equity strategy. Before joining Ally Bridge Group, Keith was an Associate in the Healthcare Investment Banking Group at Jefferies. Before that, Keith worked in investment banking at Wedbush PacGrow and Ocean Park Advisors covering biopharma and renewable energy, respectively. Keith began his career as an Analyst in the Investment Consulting Division of Wilshire Associates. Keith holds a BA in Economics and minor in Accounting from the University of California, San Diego where he graduated magna cum laude.
Jonathan Wang, CFA, CPA
Senior Associate
Private Equity
Jonathan Wang joined Ally Bridge Group in 2021 and is a Senior Associate for the private equity strategy. Before joining Ally Bridge Group, Jonathan worked as an Investment Manager at Navis Capital Partners. Before that, Jonathan worked in PricewaterhouseCoopers’ Transaction Services division. Jonathan holds an MPhil in Biochemistry from the University of Hong Kong and a BS in Applied Biology and Biotechnology from the Hong Kong Polytechnic University. He is a CFA charterholder and Certified Public Accountant.
Sam Brodovsky
Senior Associate
Private Equity
Sam Brodovosky joined Ally Bridge Group in 2024 and is a Senior Associate for the private equity strategy focused on investments in medical technology. Prior to joining Ally Bridge Group, Sam was a Medical Device Equity Research Analyst at Truist Securities. Sam began his career at PNC as an Institutional Asset Management Analyst and Equity Research at BTIG. Sam holds a Bachelor of Business Administration at Temple University.
Srishti Kotiyal, PhD
Associate
Private Equity
Srishti Kotiyal joined Ally Bridge Group in 2024 and is an Associate for the private equity strategy focused on investments in biotech. Before joining Ally Bridge Group, Srishti was an Associate in the Healthcare Investment Banking Group at Jefferies. Srishti previously interned at Eventide Asset Management and Sorenson Impact. She holds a Ph.D. in Oncological Sciences from the Huntsman Cancer Institute at the University of Utah School of Medicine and a Bachelor of Technology in Biotechnology from Jaypee Institute of Information Technology, India.
Emily Tai
Analyst
Private Equity
Emily Tai joined Ally Bridge Group in 2023 and is an Analyst for the private equity strategy focused on therapeutics. Before joining Ally Bridge Group, Emily was a summer analyst focused on healthcare and biotech at IIH Asset Management Group and 6 Dimensions Capital. Emily holds a BS in Nutritional Sciences with a minor in Business from Cornell University.
Slanix Paul Alex, PharmD
Portfolio Manager and President
Public Equity
Slanix Paul Alex joined Ally Bridge Group in 2023 and is the Portfolio Manager and President for the public equity strategy. Before joining Ally Bridge Group, Slanix invested in life sciences companies as founding Partner and Senior Analyst for Tri Locum Partners and previously as an Investment Analyst for Consonance Capital Management. Prior to the buy-side, Slanix worked in sell-side biotechnology equity research at RBC Capital Markets and Credit Suisse. Slanix began his career in strategy consulting at Bionest Partners, advising life sciences companies on business development and commercial strategy. Slanix is a licensed pharmacist and holds a PharmD from St John’s University.
Evan Zou
Senior Analyst
Public Equity
Evan Zou joined Ally Bridge Group in 2022 and is a Senior Analyst for the public equity strategy focused on investments in therapeutics. Before joining Ally Bridge Group, Evan was an Associate Director on the Portfolio Intelligence team at BridgeBio Pharma. Evan began his career as an Analyst in the Healthcare Investment Banking Group at Bank of America Securities. Evan holds a BS in Economics from The Wharton School and a BA in Biophysics from the College of Arts and Sciences at the University of Pennsylvania, where he graduated summa cum laude.
Stephen Mallon, PhD
Research Analyst
Public Equity
Stephen Mallon, PhD joined Ally Bridge Group in 2022 and is a Research Analyst for the public equity strategy focused on investments in therapeutics. Before joining Ally Bridge Group, Stephen was a Senior Research Associate at Royal Bank of Canada Capital Markets. Prior to that, Stephen was a Senior Research Associate at Chardan Capital Markets. Stephen began his career as an Investment Manager at Triwise Capital. Dr. Mallon holds a BA in Biochemistry from Bowdoin College, and he received a PhD in Microbiology from the University of Chicago.
Business Team
Hinsen Au
Senior Fund Accountant
Private Equity
Hinsen Au joined Ally Bridge Group in 2022 and is a Senior Fund Accountant for the private equity strategy. Before joining Ally Bridge Group, Hinsen was as a Senior Fund Accountant at Maples Fund Services and a Fund Services Officer at Alter Domus in Hong Kong. Hinsen began his career as an Accountant at Penske Media Corporation in New York. Hinsen holds a BBA in Accounting from Baruch College, a City University of New York.
Michael Bendetson
Chief Operating Officer, Head of Legal, Chief Compliance Officer
Public Equity
Michael Bendetson joined Ally Bridge Group in 2021 and is Chief Operating Officer, Head of Legal and Chief Compliance Officer for the public equity strategy. Before joining Ally Bridge Group, Michael was a Capital Markets Associate at Paul, Weiss, Rifkind, Wharton & Garrison LLP. Michael began his career as a Derivatives and Structured Products Associate for Davis Polk & Wardwell LLP. Michael holds a BA in Political Science from Tufts University, where he graduated magna cum laude, and he received a JD from the University of Michigan Law School.
Flora Cai
Head of Compliance
Private Equity
Flora Cai joined Ally Bridge Group in 2021 and is Head of Compliance for the private equity strategy. Before joining Ally Bridge Group, Flora was a Principal of Legal and Compliance at CPE Group where she was responsible for overseeing the compliance function for the entire team, responsible for both USD and RMB denominated private equity and hedge funds. Before that, Flora was a Director and Head of Legal and Compliance at UBS SDIC Asset Management. Flora began her career at Deacons. Flora holds an LLB from Shantou University and an LLM from the University of Hong Kong.
Susanna Chan
Executive Coordinator
Susanna Chan joined Ally Bridge Group in 2022 and is an Executive Coordinator. Before joining Ally Bridge Group, Susanna was an Executive Assistant at ShawKwei & Partners and Steve Leung Design Group. Prior to that, Susanna spent nearly a decade in investment banking administration and research as a Manager at the Carlyle Group and a Research Associate at Morgan Stanley. Susanna began her career as a Business Analyst at Goldman Sachs in Hong Kong. Susanna holds a BCom from The University of British Columbia.
Kelly Cheng, CPA
Vice President
Private Equity
Kelly Cheng joined Ally Bridge Group in 2021 and is a Vice President on the finance team. In this capacity, Kelly is responsible for corporate and general partner-related finance and operations. Before joining Ally Bridge Group, Kelly was a senior member of the Corporate Accounting team at Citadel. Before that, Kelly worked at Bank of America as a legal entity controller. Kelly began her career at PricewaterhouseCoopers and then Deloitte. Kelly holds BCom in Accounting and Economics from the University of New South Wales. She is a Certified Public Accountant.
Kevin Corb
Chief Financial Officer
Public Equity
Kevin Corb joined Ally Bridge Group in 2023 and is Chief Financial Officer for the public equity strategy. Most recently, Kevin was Managing Director and Chief Administrative Officer for Forester Capital. Prior to that, Kevin was COO/CFO/CCO for several years at Appian Way Asset Management after spending nearly 16 years in the same roles at Glenhill Capital. Kevin began his career as a fund accountant at Rothstein, Kass, & Co. offering back-office support for hedge fund clients before joining Reservoir Capital Group as the firm’s Controller. Kevin holds a BS in Business Administration from Montclair State University, Feliciano School of Business.
Autumn Langholz
Executive Coordinator
Autumn Langholz joined Ally Bridge Group in 2022 and is an Executive Coordinator. Before joining Ally Bridge Group, Autumn was an Executive Assistant at Sensiva Health, Target Corporation and Waterstone Capital Management. Autumn has more than 15 years of experience as an Executive Assistant.
Amy Lau
Executive Coordinator
Amy Lau joined Ally Bridge Group in 2021 and is an Executive Coordinator. Before joining Ally Bridge Group, Amy was an Executive Assistant at CPE Group, UBS and Citigroup. Amy has more than 15 years of secretarial experience.
Walton Lau, CPA
Finance Manager
Private Equity
Walton Lau joined Ally Bridge Group in 2022 and is a Finance Manager for the private equity strategy. Before joining Ally Bridge Group, Walton was a Finance Manager for Crypto.com. Walton began his career as an Audit Manager at KPMG where he spent six years focusing on the asset management and fund industry. Walton holds a BBA in Professional Accountancy from the Chinese University of Hong Kong and is a Certified Public Accountant.
Brendan Lavery, CFA
Head of Operations
Public Equity
Brendan Lavery joined Ally Bridge Group in 2023 and is Head of Operations for the public equity strategy. Before joining Ally Bridge Group, Brendan was an Operations Associate at HealthCor Management, LP and previously an Operations Associate at Snow Park Capital Partners, LP. Brendan began his career at International Fund Services (NA) LLC, A State Street Company, where he managed treasury operations for several hedge fund clients. Brendan holds a BS in Business Administration from Boston University and is a CFA charterholder.
Bowie Pang
Financial Controller
Private Equity
Bowie Pang joined Ally Bridge Group in 2021 and is a Financial Controller for the private equity strategy. Before joining Ally Bridge Group, Bowie was the Financial Controller at Fulcrum Global. Before that, Bowie worked in the private equity and hedge fund investment groups at TR Capital. Bowie began her career with SSG Capital where she spent over eight years working across private equity mid- and back-office functions. Bowie holds a BA in Economics from Loughborough University in England.
Zain Shekhani
Managing Director, Head of Investor Relations
Private Equity
Zain Shekhani joined Ally Bridge Group in 2024 and is a Managing Director, Head of Investor Relations for the private equity strategy. Before joining Ally Bridge Group, Zain was a Managing Director at Leon Capital Group, overseeing capital formation and investor relations for private fund offerings and investments. Before that, Zain was Co-Head of Capital Formation & Investor Relations at CRG, raising capital across CRG funds. Zain began his career in healthcare investment banking at Stifel Financial Corp. Zain holds a BS in Finance and Economics from New York University Stern School of Business.
Charles Wong, CPA
Chief Operating Officer, Chief Financial Officer
Private Equity
Charles Wong joined Ally Bridge Group in 2020 and is Chief Operating Officer and Chief Financial Officer for the private equity strategy. Before joining Ally Bridge Group, Charles spent over ten years in alternative asset management and financial services across various roles, including Chief Financial Officer at TR Capital, Vice President in the Finance team at CIitic PE and Financial Controller at DST. Charles began his career as an auditor at Deloitte in both New York and Hong Kong. Charles holds a BBA in Accounting and Finance from the Hong Kong University of Science and Technology and is a Certified Public Accountant.
Kerry Wong
Accounting Officer
Private Equity
Kerry Wong joined Ally Bridge Group in 2021 and is an Accounting Officer on the finance team. In this capacity, Kerry is responsible for corporate and general partner-related finance and operations. Before joining Ally Bridge Group, Kerry was an Accountant at DCP Capital. Kerry holds a BBS from Charles Sturt University in Australia.
Emma Yang
Director of Legal
Private Equity
Emma Yang joined Ally Bridge Group in 2022 and is Director of Legal for the private equity strategy. Before joining Ally Bridge Group, Emma was Head of Legal & Compliance for the Hong Kong office of C.M. Capital Advisors, the financial arm of Cha Group headquartered in Silicon Valley. Before that, Emma held various roles at international law firms including Mayer Brown JSM and King & Wood Mallesons. Emma holds an MCL from the University of Hong Kong and is a PRC qualified lawyer.
David Hu
Associate
Private Equity
David Hu joined Ally Bridge Group in 2024 and is an Associate on the Investor Relations team for the private equity strategy. Before joining Ally Bridge Group, David was an Associate in ECM at Credit Suisse. David started his career as an Investment Banking Analyst at China Securities International. David holds a BS in Economics (with a double minor in Statistics and Mathematics) from UCLA, and an MS in Financial Mathematics from Columbia University.
We partner with companies across their entire lifecycle.
Diversified Investment in Global Healthcare Innovation.
Our life science investments span geography and sector, as we seek to identify those firms that hold the potential to transform healthcare for society in the years to come.
We seek to leverage local relationships across the global marketplace.
Get in Touch.
Ally Bridge Group (NY) LLC
430 Park Avenue, 12th Floor
New York, New York 10022
Ally Bridge Group (HK) Limited
Suite 3902, 39/F, East Tower, Cheung Kong Center II,
10 Harcourt Road, Central, Hong Kong
For all investor inquiries, please reach out to investor.relations@ally-bridge.com.
Disclosure.
1.0 Terms of Use
Ally Bridge Group and its affiliates (together, “Ally Bridge”, “we”, or “us”) welcome you to our website (along with its accounts, pages and applications, collectively, the “Site”). By accessing, browsing and/or using the Site, you acknowledge that you have read and understand, and agree to be bound by the following terms and conditions of use and all disclaimers and terms and conditions that appear on the Site now, as well as the privacy policy of the Ally Bridge Site (the “Privacy Policy”, as set out in section 2 below, and together with the terms and conditions of use and all disclaimers and terms and conditions that appear on the Site, the “Terms”). This Site is offered to you conditioned on your acceptance without modification of the Terms contained herein. These Terms are a contract between you and Ally Bridge (the “Agreement”) and govern your visit to and use of the Site. This Agreement may be updated by us at any time. You should visit this page periodically to review the Agreement for changes. Your use of the Site, and your continued use of the Site after any such updates or modifications, constitutes your acceptance of the Terms. If you do not accept this Agreement, or if you cannot form a legally binding contract, you do not have permission to access, browse or use the Site and your sole and exclusive remedy is to discontinue using the Site.
1.1 Ownership of Materials on Site
All the material displayed on and/or accessible through the Site, including without limitation, software, text, graphics, charts, information, arrangements of information, images, articles, reports, presentations, screens, user documentation, user interfaces, related software and other material (the “Content”), is the property of Ally Bridge or others accessible via the Site and shall remain the exclusive property of Ally Bridge and its licensors, as the case may be. All Content is protected by international copyright and other laws. Nothing contained on the Site should be construed as granting, by implication, estoppel or otherwise, any license or right to use any Content without the written permission of Ally Bridge or such other party that may own the applicable Content. Nothing in this Agreement shall constitute a waiver of any trademark, copyright or other intellectual property rights. Ally Bridge reserves the right to enforce its intellectual property rights to the full extent of the law.
1.2 Restrictions on Use
The Site is for your personal education and non-commercial use. You may download or print out a hard copy of individual pages and/or sections of the Site, provided that you do not remove any copyright or other proprietary notices. Any downloading or otherwise copying from the Site will not transfer title to any software or material to you. You must not modify the paper or digital copies of any materials you have printed off or downloaded in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text. You may not reproduce (in whole or in part), transmit (by electronic means or otherwise), modify, copy, distribute, publish, license, create derivative works from, link into, sell or use for any public or commercial purpose or in any way exploit the whole or any part of the Site without the prior written permission of Ally Bridge. We reserve all rights with respect to copyright and trademark ownership of all material on the Site. You may not use the Site in any way that is fraudulent, unlawful or violates any existing agreements you may have with Ally Bridge. Any unauthorized use of the Site or misuse of any information posted to the Site is strictly prohibited. You agree that you shall not place false or misleading information on the Site or upload any computer programs, including but not limited to viruses, Trojan horses or worms that may interfere with the proper operation of our sites. Ally Bridge may, in its sole discretion, terminate your use of the Site at any time. Ally Bridge reserves the right to change, suspend or discontinue all or any aspects of our sites at any time without prior notice.
1.3 Investment Disclaimer
This Site is for informational purposes only and should not be construed as a solicitation or offer, or recommendation to acquire or dispose of any investment or to engage in any other transaction. We do not provide investment, accounting, tax, legal or other specialist advice through the Site. If you would like investment, accounting, tax or legal advice, you should consult with your own financial advisors, accountants or attorneys regarding your individual circumstances and needs. You agree that Ally Bridge is not liable for any action you take or decision you make in reliance on any Content. Ally Bridge will not treat users of the Site as its partners, clients, customers or investors by virtue of their accessing the Site.
1.4 Performance Information
The information contained on or comments expressed on the Site may include certain prior indications of past investment performance. In considering such prior performance information, you should bear in mind that past performance is not indicative of future results and there can be no assurance that any investment will, or is likely to, achieve comparable results to those achieved in the past, or that significant losses will be avoided. Any projections, market outlooks or analyses, estimates and/or statements of opinions provided on the Site are forward-looking statements and are inherently uncertain and are based on a number of assumptions. Other events which were not taken into account may occur and may significantly affect investment returns or performance. You should carefully review information regarding any such analyses and underlying assumptions. Any reference to Assets Under Management or AUM used on the Site reflect the combined Assets Under Management of Ally Bridge investment advisors as of the specific time indicated. ANY PROJECTIONS, OUTLOOKS OR ASSUMPTIONS CONTAINED IN THE INFORMATION ON THIS WEBSITE SHOULD NOT BE CONSTRUED TO BE INDICATIVE OF THE ACTUAL EVENTS WHICH WILL OCCUR.
1.5 No Reliance
While we use reasonable efforts to obtain information from sources which we believe to be reliable, and to update the information on the Site, we make no representation that the information or opinions contained in the Site are accurate, reliable, updated or complete. The information and opinions contained in the Site are provided by us for personal use and informational purposes only and are subject to change without notice. Nothing contained on the Site constitutes investment, legal, tax or other advice nor is it to be relied on in making an investment or other decision.
1.6 Third-Party Links
We may provide links from the Site to websites operated by third parties who may or may not be affiliated with Ally Bridge. We have not reviewed unaffiliated sites linked to the Site, and we do not endorse, have any responsibility for or make any representations about, any other sites, including their products and services, content, communications, opinions and website use policies. We cannot and do not make any express or implied warranty about the accuracy, copyright compliance, legality, merchantability or any other aspect of the content of such links. The use of third party websites is entirely at your own risk. By accessing these links, you acknowledge that such other sites or locations are not under the control of Ally Bridge and that Ally Bridge does not endorse the content of such sites and locations, and you agree that Ally Bridge shall not be responsible for any information or additional links found at such site or location, or for your use of such information.
1.7 Local Regulatory Restrictions
This Site is not directed to any person in any jurisdiction where (for any reason) the publication or availability of this website is prohibited, and persons in respect of whom such prohibitions apply must not access this website. Those who choose to access the Site from other locations do so at their own initiative and are responsible for compliance with local laws.
Given the global nature of the internet, this Site may be accessed by visitors residing outside of the United States. Ally Bridge makes no representations or warranties that this Site is appropriate or available for use in countries outside of the United States, or that services discussed on this Site are available or appropriate for sale or use in all jurisdictions, or by all counterparties. Visitors who choose to access this Site from outside of the United States do so at their own initiative and are responsible for compliance with any and all local laws and regulations that may apply to such access. You may not use or export the information or materials in violation of U.S. export laws and regulations.
1.8 No warranty and limitations of liability
Ally Bridge, its affiliates and their respective officers, directors, managers, partners, members, shareholders, employees, affiliates and agents (collectively “Related Persons”) make no representations or warranties and specifically disclaim any and all warranties of any kind, express or implied, with respect to the Site and the Content, including any representations or warranties with respect to merchantability, fitness for a particular purpose, title, non-infringement, availability, security, accuracy, freedom from viruses or malware, completeness, timeliness, functionality, reliability, sequencing or speed of delivery. Your use of the Site and the Content is on an “as is” and “as available” basis. If you are not able to use or access the Site, or any websites linked to through the Site, Ally Bridge is not responsible for any problems that this causes.
In no event shall Ally Bridge, its affiliates or their Related Persons be liable to any party for any claims, liabilities, losses, costs or damages under any theory, including but not limited to any direct, indirect, punitive, special, incidental, or consequential damages arising out of in connection with any access, use (or inability to use) or distribution of the Site, or any Content therein, even if Ally Bridge or their related persons are advised of the possibility of such damages, losses or expenses. You acknowledge and agree that you may not bring a claim against Ally Bridge relating to your use of the Site after more than one year has passed since the event occurred that gave rise to the claim, while there is no such limitation on Ally Bridge’s right to bring claims against you. You acknowledge and agree that the disclaimers, including the warranty disclaimers, and the liability and remedy limitations in this Agreement are material terms of this Agreement and that they have been taken into account in the decision by Ally Bridge to provide the Site hereunder.
1.9 Governing Law
The Site is made available to you from the State of New York. The laws of New York will govern this Agreement (including any disputes concerning or related to this Agreement). The courts of New York have exclusive jurisdiction to settle any dispute, controversy or claim arising from or connected with this Agreement. Notwithstanding the foregoing, you expressly acknowledge and agree that Ally Bridge may seek injunctive or other appropriate relief in any court of competent jurisdiction and you consent to exclusive jurisdiction and venue in such courts. This Agreement is a personal agreement between you and Ally Bridge, and no one shall be a third party beneficiary to this Agreement. If any provision of this Agreement shall be unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from this Agreement, shall be enforced to the fullest extent allowed by law as to effect the intention of the parties, and shall not affect the validity and enforceability of any remaining provisions.
2.0 Privacy Policy
This privacy policy (the “Privacy Policy”) applies to your access and use of the Site and use of the Ally Bridge websites and/or other online programs, or the materials, software and content available in or through them (altogether, the “Site”). An important part of our commitment to you is our respect for your privacy as a user of the Site. This Privacy Policy seeks to help you understand whether and how we collect information about you when you visit the Site, and how we use such information.
Your visit to the Site is subject to this Privacy Policy and our Terms. By visiting, using and/or downloading any information available on the Site, you agree to this Privacy Policy and our Terms, which may be updated by us at any time, and consent to all actions that we take with respect to your data consistent with this Privacy Policy and our Terms. If you do not agree to this Privacy Policy or the Terms, you are instructed not to use this website. If we update our Privacy Policy, we will post the updated Privacy Policy here. Any such changes will be effective upon posting. You should visit this page periodically to review the Privacy Policy for changes. This privacy policy does not apply to information Ally Bridge collects offline or through email.
2.1 Information We Collect About You
We may make sensitive permissions requests and/or automatically collect information about your computer, tablet, mobile device or other electronic device when you visit our Site. This information may include your Internet Protocol (IP) address, Internet Service Provider (ISP), domain name, browser type, date and time of your request and information. We do not employ cookies. If you voluntarily submit information to our website, for example, in a request for general information or through the submission of a business proposal, we may record and use any personally identifiable information, financial information, authentication information, phonebook or contact data and sensitive device data for reasonable business purposes including, but not limited to, fulfilling your request. You acknowledge that you assume all responsibility related to the security, privacy and risks inherent in sending any content over the Internet.
2.2 Use of Information We Collect
Ally Bridge does not disclose any nonpublic personally identifiable information about its Site users to any nonaffiliated third party, except as set forth below.
We may use or disclose certain personally identifiable information we collect about you when you visit and browse the Site as part of our normal business operations, or to send you administrative communications either about your interactions with us or about features of the Site, including any future changes to this Privacy Policy. We may also use service providers to facilitate our services or platform functions on our behalf. These companies and individuals may have access to your personally identifiable information, as needed to perform their functions, but may not use it for another purpose. We will use or disclose personally identifiable information when we believe that such disclosures are required by law, regulation, legal process, subpoena, document request or governmental request, and we may disclose your communications and activities on the Site in response to requests by any government agency. Ally Bridge reserves the right to use any personally identifiable information in any manner permitted by law.
2.3 Protection of Information
We endeavor to protect your personally identifiable information. We use technical, administrative and physical methods to maintain the integrity and security of our databases, including firewalls. This website is not absolutely protected against unauthorized third parties. You acknowledge that any information provided through the Internet may be potentially accessed by unauthorized third parties. Although We will make reasonable efforts to protect the privacy of users of the Site, no guarantee can be made that unauthorized third parties will not access the information contained on the Site. You acknowledge that Ally Bridge is not responsible for notifying you that unauthorized third parties have gained such access or that any data has been otherwise compromised during transmission across computer networks or telecommunications facilities, including, but not limited to, the Internet. We will not be responsible or liable for any damages, losses or causes of action arising out of or in connection with the disclosure of your personally identifiable information.